survived by the skin of our teeth |
Also looks like IPO will survive the FTSE 250 reshuffle today. Fingers crossed... |
ONT results have been well received ,revenue to grow by more than 30% CAGR thats a decent growth rate out to 2027 . |
Following the ONT results to 30/6/2024, there is the US version of London Calling in Boston, Monday 16th - Tuesday 17 September 2024
It's thought that there will be more info presented on the clinical uses for ONT that are coming to the market over the next year, both directly and via various partners.
A month later on the 5th October 2024, the management anti-takeoevr shares will expire, leaving the co open to possible takeover activity and inclusion in various indices/tracker funds etc. |
Tuesday 3rd Sept ONT report. |
lets hope featurespace lawyers are burning the midnight oil this weekend. |
Share buybacks are handled by a broker based on defined rules, which are usually designed to ensure that the company doesn't bid up its own share price. (which, among other reasons, could be taken advantage of by hedge funds)
If the share buyback amounts have spiked lately, I would guess that this is due to increased selling due to funds getting ahead of the upcoming FTSE250 relegation. |
Another notable spike.
In the last two months the daily levels of buy backs as a percentage of volume has increased. Recently hit 25% of the days volume. Early in this buy back it was as low as 5% IPO clearly feel more strongly about the value down here! Or are they seeing nice realisations in the near future? |
Chrysalis certainly seems to have spiked on the Featurespace rumours. Probably CHRY is better covered than IPO - with a much clearer distribution policy for funds from realisations.
Topped up IPO today, hoping to see at least a 10-20% jump in IPO if the sale to Visa happens and management says sensible things about the proceeds... |
well i guess the market needs to see the marriage confirmed first. |
Yes a pretty unique situation here. Large discount to NAV, large buyback in operation and expected sale of one of the larger assets at double NAV. Doesn't get much better. |
edward, thanks for info. I didn't realise it had been confirmed. |
We have been kicked out of ftse 250 which means trackers thereof have to sell |
ed, what is tracker selling?
Probably being naïve, but I'm confused by the continuous selling without regard for price obtained. You'd think a seller would want to get the most they can, not the least!
Interesting to look online with regard to the breadth of past Visa takeovers |
Would laugh if tracker selling finishes just as featurespsce confirms its sake to visa |
it appears chrysallis held featurespace at higher valuation to ipo. |
Microbiotica’s Microbiome Medicines in Melanoma and Ulcerative Colitis Gain Regulatory Approvals in EU and UK for Phase 1b Studies
IPO has 17.7% holding |
you'd hope visa is a more credible suitor than hambro perks. |
The last time a deal [Istesso] was mooted on SKY it was Hambro Perks, we didn't get many details, and the speculation ended in the blink of an eye.
At least this time, the constituent involved is a seemingly viable business. |
Probably a buy on Tuesday if that deal cements |
Ref previous post: IPO certainly needs something to kick it towards something approaching respectable performance and I've given up expecting anything from the directors of this company. Deus ex machina would do nicely, thank you to help it on the way.
We are now below where we were during darkest days of lockdown. What a rotten pile of doggie-doo. Good luck to anybody who dived in recently and LTHs too.
I wonder if the board ever feel a touch of shame - or regret - when (or indeed if) they look at the share price performance? Bamboo2 says they are v. nice people but being nice isn't really a prerequisite to being a good leader or director. Hopeless. |
hxxps://news.sky.com/story/lynch-backed-featurespace-in-talks-about-visa-takeover-13202036
This is, potentially, very very positive for IP.
IP owns 20.1% of Featurespace and was carrying it at £73m as at 31 Dec 23 or 7.0p per share. This gives an implied valuation of £363m. A takeover at c£700m would therefore represent c£140m in cash or c14.0p per share, all assuming no preferential share rights for IP or any other shareholders. This equates to roughly 14% of NAV or 33% of the current share price. |
I read in Proactive that IPO probably about to be relegated from the FTSE 250. |
scooby, read this... |
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Hot Features
Premium
